NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Copaxone Subcutaneous Injection Syringe Special Drug Use-Result Investigation (All-Case Investigation) "Prevention of Relapse of Multiple Sclerosis"

NCT03209479

CompletedN/A

Sponsor: Teva Takeda Pharma Ltd.

Conditions: Multiple Sclerosis

Interventions: Glatiramer acetate

Countries: Japan

The purpose of this study is to evaluate the safety and efficacy of Copaxone subcutaneous injection syringe (hereinafter referred to as Copaxone) in patients with multiple sclerosis in the routine clinical setting.

Eligibility overview

Sex: ALL

Healthy volunteers: No

Study type: OBSERVATIONAL

Eligibility criteria

Inclusion Criteria:

\- All patients treated with Copaxone from the first day of market launch of the product

Exclusion Criteria:

-None

Locations (1)

Tokyo, Japan